Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in
Hepatitis C Monday November 10, 5:00 am ET http://biz.yahoo.com/prnews/081110/clm059.html?.v= 101 PRINCETON, N.J., Nov. 10 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS - News), Roche (SWX: ROG - News) and InterMune, Inc. (Nasdaq: ITMN - ...